Alnylam completes follow-on

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Cancer Date completed: 2015-01-20 Type: Follow-on Raised: $450 million Shares: 4.7 million Price...